Most viewed in the last 7 days from JAMA Otolaryngology – Head & Neck Surgery: Are CD44 and total protein useful for monitoring head and neck cancer recurrence, either used in a point-of-care test or as individual laboratory-based biomarkers? ja.ma/470GY3D

This cohort study defines clinical and genetic risk factors for ICI-induced diabetes, highlighting phenotypic heterogeneity and implications for personalized immunotherapy. ja.ma/3MoT9xH

From JAMA: JAMA Clinical Guidelines Synopsis: the 2023 American Association for the Study of Liver Diseases practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. ja.ma/3AJzUfJ

Listen to an interview with Michelle Rengarajan, author of "Identification of Immune Checkpoint Inhibitor–Induced Diabetes," and Vivek Subbiah, MD. Hosted on AMA Ed Hub™. ja.ma/3WZvYPs

🚨Perfect podcast to listen before the long weekend. Our conversation is a must-listen for anyone interested in the cutting-edge intersections of oncology/ immunology/endocrinology JAMA JAMA Oncology OncoAlert

In this meta-analysis, neoadjuvant ICI improves efficacy outcomes in early-stage triple-negative breast cancer (TNBC) and PD-L1+ HR+/HER2- tumors. However, in TNBC no benefit was observed with adjuvant ICI in patients with either pCR or residual disease. ja.ma/3XpQzhr

Most viewed in the last 7 days from JAMA Oncology: How frequently do cardiovascular adverse events occur in patients treated with immune checkpoint inhibitors and how should clinicians manage myocarditis in particular? ja.ma/3X3Pvy9

From JAMA Surgery: Unlocking insights in liver cancer treatment: study compares LR, PRFA, and TACE in patients with multinodular BCLC-A, revealing superior survival with LR. Therapeutic hierarchy holds in these cases. ja.ma/3Me4sIR #LiverCancer #SuperiorSurvival

Systematic review identifies disparities between real-world data (RWD) and prospective trial data in eligibility criteria, statistical rigor, outcome monitoring, and toxicity reporting. These gaps undermine conclusions in most RWD-controlled studies. ja.ma/3WZvZD0

From JAMA Network Open: Study finds racial disparities in adolescent & young adult (AYA) cancer outcomes. Indigenous population have lower cancer survival rates for cancers w/ widest survival gaps. Indigenous inclusion is necessary in AYA cancer research. ja.ma/3XldhqN

⭐️Identification of Immune Checkpoint Inhibitor–Induced Diabetes - was just published JAMA Oncology JAMA 👉🏼 Delighted to host a podcast with the lead author Dr. Michelle Rengarajan, Physician-scientist Harvard Medical School MassGeneral News Hosted on AMA Ed Hub™

This JAMA Oncology Patient Page describes cardio-oncology, a relatively new area in medicine that focuses on taking care of the heart while going through cancer treatments. ja.ma/3T7rJ38

Authors Heather McGee, MD PhD Terry Williams and Percy Lee MD explain differences between recent studies using radiotherapy with immunotherapy and possible reasons for their different outcomes. ja.ma/3Xa4S8y City of Hope - Department of Radiation Oncology

Systematic review found that 43% of randomized clinical trials of anticancer treatment in the adjuvant or neoadjuvant context failed to present any assessable postrecurrence treatment data. ja.ma/3YMKZGH

⭐️Nice editorial on “Neoadjuvant Immunotherapy in Breast Cancer - from #ClinicalTrials to #Practice” Dr. E Mittendorf Sara Tolaney JAMA Oncology JAMA jamanetwork.com/journals/jamao…

From JAMA Network Open: People w/ or without blood cancers had similar rates of cognitive decline before, around the time & after diagnosis, suggesting the cognitive trajectory of older adults with blood cancer parallels the trajectory seen in normal aging. ja.ma/4dIC1iA

Standardized surveillance enables early detection of new tumors across a wide spectrum of cancer predisposition syndromes in children and young adult, allowing for complete surgical resection and successful treatment in the majority of patients. ja.ma/3ADGPqA

In this diagnostic study, among Black patients who underwent hysterectomy, a significant proportion of those with endometrial cancer had endometrial thickness below the range of diagnostic thresholds for detection. Tissue sampling is strongly recommended. ja.ma/3TgpxX5

Most viewed in the last 7 days from JAMA Oncology: How frequently do cardiovascular adverse events occur in patients treated with immune checkpoint inhibitors and how should clinicians manage myocarditis in particular? ja.ma/3Mq1rFD

Findings of this study suggest that disparities exist in the inpatient management of people experiencing homelessness with cancer, highlighting opportunities to improve care delivery and outcomes among this socioeconomically vulnerable patient population. ja.ma/3Tg8LHL